Protective Effects of the Alga Fucoidan Against Amyloid-β-Induced Neurotoxicity in SH-SY5Y Cells

  • Nagata Miki
    Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa University School of Pharmacy Pharmacological Research Center, Showa University
  • Tsuji Mayumi
    Pharmacological Research Center, Showa University
  • Oguchi Tatsunori
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Momma Yutaro
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Nohara Tetsuhito
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Ohashi Hideaki
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Ito Naohito
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Yamamoto Ken
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Udaka Yuko
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Sasaki Akiko
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Kiuchi Yuji
    Pharmacological Research Center, Showa University Department of Pharmacology, Division of Medical Pharmacology, School of Medicine, Showa University
  • Numazawa Satoshi
    Division of Toxicology, Department of Pharmacology, Toxicology and Therapeutics, Showa University School of Pharmacy Pharmacological Research Center, Showa University

この論文をさがす

抄録

<p>Dementia is expected to affect an increasing number of patients with global aging populations. About 70% of all dementia is related to Alzheimer's disease (AD). Overaccumulation of amyloid-β protein (Aβ) in the brain forms senile plaques, one of the main features of neurodegeneration in AD. However, there are few drugs available to specifically inhibit senile plaque formation. Fucoidan, a sulfated polysaccharide derived from brown algae, has various bioactivities, such as anti-tumoral and anti-obesity effects. This study aimed to clarify the mechanism underlying the protective effect of fucoidan against Aβ-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. Cell viability and Aβ-induced cytotoxicity were measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, calcein AM, and ethidium homodimer-1. Aβ-induced oxidative stress was evaluated through reactive oxygen species (ROS), cell membrane phospholipid peroxidation, mitochondrial ROS, and Mn-SOD, a mitochondrial radical scavenger. In addition, mitochondrial membrane permeability transition, and ATP concentration were evaluated. Fucoidan significantly improved Aβ-reduced cell viability. With respect to oxidative stress, Aβ exposure increased ROS, lipid peroxidation, and mitochondrial ROS, while fucoidan significantly suppressed these changes. Fucoidan also suppressed the decline in mitochondrial permeability transition and ATP caused by Aβ. Therefore, through its numerous antioxidant activities, fucoidan might have a neuroprotective role in preventing Aβ-induced neurotoxicity.</p>

収録刊行物

  • BPB Reports

    BPB Reports 4 (6), 206-213, 2021

    公益社団法人 日本薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (41)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ